[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Agilent Technologies (A)

Agilent Technologies (A)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Agilent Research Catalyst Award Presented to Eastern Institute of Technology, Ningbo

Eastern Institute of Technology professor recognized for advancing PFAS and emerging contaminant analysis

A : 140.30 (-0.17%)
Agilent to Announce Third-Quarter Fiscal Year 2026 Financial Results on Aug. 26

Agilent Technologies Inc. (NYSE: A) will release financial results for the third quarter of fiscal year 2026 after the stock market closes on Wednesday, Aug. 26. The company will host a conference call...

A : 140.30 (-0.17%)
What to Expect From Agilent Technologies' Q3 2026 Earnings Report

Agilent Technologies is poised to release its third-quarter results soon, and analysts are projecting a single-digit earnings rise.

A : 140.30 (-0.17%)
XLV : 166.24 (-0.61%)
$SPX : 7,316.15 (-1.52%)
1 Healthcare Stock to Research Further and 2 We Avoid

1 Healthcare Stock to Research Further and 2 We Avoid

A : 140.30 (-0.17%)
STE : 234.83 (+1.95%)
UNH : 420.57 (-1.92%)
Agilent Receives EU Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma

Approval expands PD-L1 testing to support treatment decisions with KEYTRUDA ® (pembrolizumab)

A : 140.30 (-0.17%)
1 of Wall Street’s Favorite Stocks on Our Buy List and 2 We Brush Off

1 of Wall Street’s Favorite Stocks on Our Buy List and 2 We Brush Off

APP : 399.46 (-4.49%)
A : 140.30 (-0.17%)
STZ : 131.75 (-0.20%)
Agilent Receives FDA Approval for PD-L1 IHC 28-8 pharmDx in Esophageal Squamous Cell Carcinoma (ESCC), Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinoma

Test enables identification of patients whose tumors express PD-L1 and who may be eligible for treatment with OPDIVO® (nivolumab) or OPDIVO QVANTIG®

A : 140.30 (-0.17%)
Agilent (A): Buy, Sell, or Hold Post Q1 Earnings?

Agilent (A): Buy, Sell, or Hold Post Q1 Earnings?

A : 140.30 (-0.17%)
Agilent Expands Altura Portfolio with Inert Size Exclusion and PLRP-S Columns for Biotherapeutic Analysis

Agilent Technologies Inc. (NYSE: A) today announced the latest expansion of its Altura HPLC column portfolio with the introduction of Altura size exclusion chromatography (SEC) and Altura PLRP-S...

A : 140.30 (-0.17%)
Agilent Launches AI-Driven Analysis Module for Agilent xCELLigence RTCA eSight

Simplifying label-free imaging analysis for more confident real-time cell analysis

A : 140.30 (-0.17%)

Barchart Exclusives

This Dividend Stock Is Up 22% in a Month Despite Mixed Q2 Earnings. Don’t Sell Just Yet.
Domino’s Pizza stock has rebounded sharply from its 2026 lows. While its valuation multiples have expanded and DPZ does not look as tempting now, dividend investors can stay put in the stock. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.